Emerging studies suggest this peptide, a dual stimulator targeting both GLP-1 and GIP , appears to represent a promising development for weight loss . Initial patient trials have indicated substantial https://getretatrutideaustralia.com/blog/retatrutide-vs-tirzepatide-semaglutide